Targeting IL13Rα2 in melanoma with a bispecific T-cell engager: expression profiling and preclinical evaluation

Background Melanoma is a highly aggressive skin cancer, especially in advanced stages. While current treatments such as targeted therapies and immunotherapies have made significant progress, challenges like drug resistance and limited effectiveness in some patients persist. Therefore, ongoing develo...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	David B Weiner, Meenhard Herlyn, Pratik S Bhojnagarwala, Daniel H Park, Shushu Zhao, Yeqing Chen, Cory Livingston, Joshua Jose, Yangcheng Gao
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMJ Publishing Group 2025-06-01
Σειρά:	Journal for ImmunoTherapy of Cancer
Διαθέσιμο Online:	https://jitc.bmj.com/content/13/6/e011073.full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!